A large real-world study from China found that AI-assisted upper endoscopy nearly doubled the detection of high-risk gastric lesions (HrGLs),…
Browsing: Clinical Updates
Jona has expanded its Clinical Gut Microbiome Analysis platform by adding stool biomarkers such as calprotectin, secretory IgA, and short-chain…
The American Cancer Society has updated its colorectal cancer screening guidance, reaffirming that average-risk adults should begin screening at age…
In the ASTRO phase 3 abstract, adults with moderately to severely active ulcerative colitis receiving subcutaneous guselkumab induction had a…
Virtual colonoscopy is gaining renewed attention as a less invasive alternative to traditional colonoscopy, particularly for patients reluctant to undergo…
A noninvasive magnetic neuromodulation therapy significantly improved fecal incontinence symptoms in a sham-controlled Phase 3 trial, with responder rates reaching…
The medical management of obesity is changing, thanks in part to new views on obesity and widespread adoption of weight-loss…
Guardant Health has received FDA approval for its next-generation liquid biopsy platform, Guardant360 Liquid CDx, expanding the role of blood-based…
Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn’s disease and ulcerative colitis, affects about 1.6 million Americans, many…
Disorders of gut–brain interaction (DGBI), previously referred to as functional gastrointestinal disorders (FGID), have been poorly understood historically. Although providers…